CompletedPhase 2NCT00462462
Systemic and Local Diffusion of Ethanol After Administration of Ethanol 96% Formulated in a Gel and Ethanol 98% Solution by the Percutaneous Route, in Patients With Congenital Venous Malformations:Pharmacokinetic, Pharmacodynamic and Clinical Study.
Studying Congenital anomaly of the great veins
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Orfagen
- Principal Investigator
- PATRICK DUPUY, MD, MDORFAGEN LABORATORIES (France)
- Intervention
- Ethanol 96% Gel(drug)
- Enrollment
- 32 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2007 – 2010
Study locations (2)
- Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
- Hôpital Bretonneau Service de neuroradiologie, Tours, France
Collaborators
FDA Office of Orphan Products Development
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00462462 on ClinicalTrials.gov